{
    "Trade/Device Name(s)": [
        "Liberty\u2122 Blood Glucose Monitoring System",
        "AgaMatrix Liberty Blood Glucose Meter",
        "AgaMatrix Liberty Blood Glucose Test Strips",
        "AgaMatrix Liberty Control Solutions"
    ],
    "Submitter Information": "AgaMatrix, Inc.",
    "510(k) Number": "K063409",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052762"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "January 12, 2007",
    "Summary Letter Received Date": "November 13, 2006",
    "Submission Date": "November 9, 2006",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Liberty Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Meter",
        "Test Strips",
        "Control Solutions"
    ],
    "Document Summary": "FDA 510(k) summary for Liberty Blood Glucose Monitoring System for quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, or forearm.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, or forearm; for home use by people with diabetes and for use in clinical settings by healthcare professionals; not intended for use with neonates.",
    "fda_folder": "Clinical Chemistry"
}